Carriers of the Apoε4 allele have significantly higher risk of developing late-onset AD and in mouse models of AD pathology, Apoε4 promotes neuroinflammatory responses leading to neurodegeneration, independent of its effects of Aβ processing [6, 36, 37]. Here, APOE is linked to Alzheimer disease.